HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$11.02
Day range
$10.96 - $11.42
Year range
$4.09 - $15.34
Market cap
316.14M USD
Avg Volume
1.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 18.31M | 1.91% |
Operating expense | 37.21M | -11.74% |
Net income | -18.26M | 19.43% |
Net profit margin | -99.68 | 20.94% |
Earnings per share | -0.85 | 20.56% |
EBITDA | -17.68M | 25.04% |
Effective tax rate | -0.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 204.11M | -11.29% |
Total assets | 301.03M | -24.52% |
Total liabilities | 221.75M | -11.27% |
Total equity | 79.28M | — |
Shares outstanding | 21.38M | — |
Price to book | 2.97 | — |
Return on assets | -15.14% | — |
Return on capital | -15.85% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -18.26M | 19.43% |
Cash from operations | 17.51M | 218.48% |
Cash from investing | -26.48M | -317.38% |
Cash from financing | -6.42M | 3.35% |
Net change in cash | -15.40M | 44.53% |
Free cash flow | 24.63M | 247.05% |
About
Founded
1995
Headquarters
Website
Employees
131
